Intravenous isoprenaline and orciprenaline as a guide to the drug treatment of Stokes-Adams attacks.
D000219:Adams-Stokes Syndrome / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D004562:Electrocardiography; D005260:Female; D006327:Heart Block / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D012118:Resorcinols / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol; D007545:Isoproterenol